Literature DB >> 7635111

Using biological monitoring to assess human exposure to priority toxicants.

J L Pirkle1, E J Sampson, L L Needham, D G Patterson, D L Ashley.   

Abstract

Scientifically valid exposure assessment is crucial to risk assessment, risk management, and prevention of environmental disease. Scientists have used three tools to assess exposure: exposure history/questionnaire, environmental monitoring (including personal monitoring), and biological monitoring. Combinations of these tools usually provide the exposure information needed to meet objectives of human studies evaluating the exposure-health effect relationship. Biological monitoring is a capable exposure assessment tool that has provided important information used in public health decisions. We briefly describe how risk assessment and risk management decisions for lead, dioxin, and volatile organic compounds have substantially benefited from exposure information obtained from biological monitoring.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635111      PMCID: PMC1519023          DOI: 10.1289/ehp.95103s345

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  6 in total

1.  Determining volatile organic compounds in human blood from a large sample population by using purge and trap gas chromatography/mass spectrometry.

Authors:  D L Ashley; M A Bonin; F L Cardinali; J M McCraw; J S Holler; L L Needham; D G Patterson
Journal:  Anal Chem       Date:  1992-05-01       Impact factor: 6.986

2.  Chronological trend in blood lead levels between 1976 and 1980.

Authors:  J L Annest; J L Pirkle; D Makuc; J W Neese; D D Bayse; M G Kovar
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245

3.  Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Vietnam Veterans of Operation Ranch Hand.

Authors:  J L Pirkle; W H Wolfe; D G Patterson; L L Needham; J E Michalek; J C Miner; M R Peterson; D L Phillips
Journal:  J Toxicol Environ Health       Date:  1989

4.  Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  M A Fingerhut; W E Halperin; D A Marlow; L A Piacitelli; P A Honchar; M H Sweeney; A L Greife; P A Dill; K Steenland; A J Suruda
Journal:  N Engl J Med       Date:  1991-01-24       Impact factor: 91.245

5.  Blood concentrations of volatile organic compounds in a nonoccupationally exposed US population and in groups with suspected exposure.

Authors:  D L Ashley; M A Bonin; F L Cardinali; J M McCraw; J V Wooten
Journal:  Clin Chem       Date:  1994-07       Impact factor: 8.327

6.  Serum concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin and test results from selected residents of Seveso, Italy.

Authors:  P Mocarelli; L L Needham; A Marocchi; D G Patterson; P Brambilla; P M Gerthoux; L Meazza; V Carreri
Journal:  J Toxicol Environ Health       Date:  1991-04
  6 in total
  10 in total

1.  Tracking toxins. Biomonitoring outshines the indirect assessment of exposure in determining which pollulants enter the body, and whether they cause disease or disability.

Authors:  Barbara Scott Murdock
Journal:  EMBO Rep       Date:  2005-08       Impact factor: 8.807

2.  Reconstructing population exposures to environmental chemicals from biomarkers: challenges and opportunities.

Authors:  Panos G Georgopoulos; Alan F Sasso; Sastry S Isukapalli; Paul J Lioy; Daniel A Vallero; Miles Okino; Larry Reiter
Journal:  J Expo Sci Environ Epidemiol       Date:  2008-03-26       Impact factor: 5.563

Review 3.  The use of biomonitoring data in exposure and human health risk assessment: benzene case study.

Authors:  Scott M Arnold; Juergen Angerer; Peter J Boogaard; Michael F Hughes; Raegan B O'Lone; Steven H Robison; A Robert Schnatter
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635

4.  Allylmercapturic acid as urinary biomarker of human exposure to allyl chloride.

Authors:  B M de Rooij; P J Boogaard; J N Commandeur; N J van Sittert; N P Vermeulen
Journal:  Occup Environ Med       Date:  1997-09       Impact factor: 4.402

Review 5.  Personalized exposure assessment: promising approaches for human environmental health research.

Authors:  Brenda K Weis; David Balshaw; John R Barr; David Brown; Mark Ellisman; Paul Lioy; Gilbert Omenn; John D Potter; Martyn T Smith; Lydia Sohn; William A Suk; Susan Sumner; James Swenberg; David R Walt; Simon Watkins; Claudia Thompson; Samuel H Wilson
Journal:  Environ Health Perspect       Date:  2005-07       Impact factor: 9.031

6.  The association between biomarker-based exposure estimates for phthalates and demographic factors in a human reference population.

Authors:  Jung-Wan Koo; Frederick Parham; Michael C Kohn; Scott A Masten; John W Brock; Larry L Needham; Christopher J Portier
Journal:  Environ Health Perspect       Date:  2002-04       Impact factor: 9.031

7.  Levels of seven urinary phthalate metabolites in a human reference population.

Authors:  B C Blount; M J Silva; S P Caudill; L L Needham; J L Pirkle; E J Sampson; G W Lucier; R J Jackson; J W Brock
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

8.  Safety recommendations for moxa use based on the concentration of noxious substances produced during commercial indirect moxibustion.

Authors:  O Sang Kwon; Seong Jin Cho; Kwang-Ho Choi; Sun Hee Yeon; Suk-Yun Kang; Jae-Hyo Kim; Seong-Hun Ahn; Yeonhee Ryu
Journal:  Acupunct Med       Date:  2016-08-11       Impact factor: 2.267

9.  Source reconstruction of airborne toxics based on acute health effects information.

Authors:  Christos D Argyropoulos; Samar Elkhalifa; Eleni Fthenou; George C Efthimiou; Spyros Andronopoulos; Alexandros Venetsanos; Ivan V Kovalets; Konstantinos E Kakosimos
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

10.  Methyl Tertiary-Butyl Ether Exposure from Gasoline in the U.S. Population, NHANES 2001-2012.

Authors:  Lalith K Silva; Michael F Espenship; Brittany N Pine; David L Ashley; Víctor R De Jesús; Benjamin C Blount
Journal:  Environ Health Perspect       Date:  2019-12-10       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.